Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)

Masanobu Takahashi, Ken Kato, Morihito Okada, Keisho Chin, Shigenori Kadowaki, Yasuo Hamamoto, Yuichiro Doki, Yutaro Kubota, Hisato Kawakami, Takashi Ogata, Hiroki Hara, Manabu Muto, Yuichiro Nakashima, Ryu Ishihara, Masahiro Tsuda, Satoru Motoyama, Mamoru Kodani, Yuko Kitagawa

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)'. Together they form a unique fingerprint.

Medicine & Life Sciences